Spots Global Cancer Trial Database for childhood burkitt lymphoma

Every month we try and update this database with for childhood burkitt lymphoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Combination Chemotherapy in Treating Children With Stage III or Stage IV Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia	NCT00003217	Leukemia Lymphoma	filgrastim cyclophosphamid... cytarabine dexamethasone doxorubicin hyd... methotrexate vincristine sul...	- 21 Years	Children's Oncology Group
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology	NCT02847130	Acute Lymphobla... B-Cell Non-Hodg... Childhood Acute... Childhood Burki... Childhood Neopl... Hematopoietic a... Malignant Solid... Recurrent Child...	Informational I... Interview Medical Chart R... Questionnaire A...	- 20 Years	Children's Oncology Group
TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma	NCT00002757	Leukemia Lymphoma	filgrastim cyclophosphamid... cytarabine doxorubicin hyd... etoposide methotrexate prednisolone prednisone therapeutic hyd... vincristine sul...	- 20 Years	Children's Oncology Group
Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma	NCT00002471	Leukemia Lymphoma	asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone etoposide leucovorin calc... methotrexate methylprednisol... therapeutic hyd... thiotepa vincristine sul...	-	Memorial Sloan Kettering Cancer Center
Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia	NCT00005977	Leukemia Lymphoma	filgrastim cyclophosphamid... cytarabine dexamethasone doxorubicin hyd... etoposide ifosfamide leucovorin calc... methotrexate vincristine sul...	- 22 Years	Children's Oncology Group
Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma	NCT00363272	Childhood Burki... Childhood Centr... Childhood Choro... Childhood Crani... Childhood Grade... Childhood Grade... Childhood Grade... Childhood High-... Childhood Infra... Childhood Low-g... Childhood Spina... Childhood Supra... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Unspecified Chi...	ispinesib laboratory biom... pharmacological...	1 Year - 21 Years	National Cancer Institute (NCI)
Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia	NCT00058461	B-cell Childhoo... Childhood Burki... Childhood Diffu... Childhood Immun... L3 Childhood Ac... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child...	ifosfamide etoposide rituximab carboplatin filgrastim methotrexate cytarabine laboratory biom...	- 21 Years	National Cancer Institute (NCI)
TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma	NCT00002757	Leukemia Lymphoma	filgrastim cyclophosphamid... cytarabine doxorubicin hyd... etoposide methotrexate prednisolone prednisone therapeutic hyd... vincristine sul...	- 20 Years	Children's Oncology Group
Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer	NCT00004132	Drug/Agent Toxi... Leukemia Lymphoma Multiple Myelom... Oral Complicati... Radiation Toxic...	filgrastim palifermin cyclophosphamid... etoposide ifosfamide quality-of-life... radiation thera...	12 Years - 65 Years	National Cancer Institute (NCI)
Studying Genes Associated With Non-Hodgkin Lymphoma in Young Patients	NCT01623856	Childhood Burki... Childhood Lymph...	laboratory biom...	- 20 Years	Children's Oncology Group
Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia	NCT00058461	B-cell Childhoo... Childhood Burki... Childhood Diffu... Childhood Immun... L3 Childhood Ac... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child...	ifosfamide etoposide rituximab carboplatin filgrastim methotrexate cytarabine laboratory biom...	- 21 Years	National Cancer Institute (NCI)
Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma	NCT00057811	Childhood Burki... Childhood Diffu... Childhood Immun... Stage I Childho... Stage I Childho... Stage II Childh... Stage II Childh... Stage III Child... Stage III Child... Stage IV Childh... Stage IV Childh... Untreated Child...	doxorubicin hyd... cyclophosphamid... methotrexate rasburicase leucovorin calc... prednisone methylprednisol... filgrastim rituximab cytarabine etoposide vincristine sul... hydrocortisone ... laboratory biom...	1 Year - 29 Years	Children's Oncology Group

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: